ARCHIVES

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

DCE Board Approves Recompetitions, Program Announcement For Research On Fish

July 7, 1989

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More

July 3, 1987